Halozyme Therapeutics paid its 5 named executives $37.5M in total in FY2025 (Dec). CEO Helen I. Torley was paid $23.2M of that.
Pay$100 in the stock at the end of FY20 → $158
Pay of each named executive
Helen I. TorleyPresident and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Nicole LaBrosseSenior Vice President, Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Mark SnyderSenior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Cortney CaudillSenior Vice President, Chief Operating Officer
| FY2025 (Dec) |
1 year
Michael J. LaBarreFormer Senior Vice President, Chief Technical Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $16.3M. The CEO of Halozyme Therapeutics was paid $23.2M, 43% above the median.
- 1Exelixis
- 2PTC Therapeutics
- 3Halozyme TherapeuticsThis company
- 4Biomarin Pharmaceutical
- 5United Therapeutics
- 6INSMED
- 7Ionis Pharmaceuticals
- 8Alkermes plc.
- 9Neurocrine Biosciences
- 10Acadia PharmaceuticalsNot disclosed
- 11Amicus TherapeuticsNot disclosed
- 12Apellis PharmaceuticalsNot disclosed
- 13BeiGeneNot disclosed
- 14Blueprint MedicinesNot disclosed
- 15Denali TherapeuticsNot disclosed
- 16Intra-Cellular TherapeuticsNot disclosed
- 17Ironwood PharmaceuticalsNot disclosed
- 18Sarepta TherapeuticsNot disclosed
- 19Ultragenyx PharmaceuticalsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.